Research/Studies

Clinical Studies Utilizing Bio-Tech Pharmacal Products

Below is a list of some Completed Clinical Studies utilizing Bio-Tech Pharmacal products. However, various other clinical studies are being conducted but have not been completed and published yet.

Study Information Institutions and Investigators
1. Bio-Tech D3-50,000 IU The Kidney Institute, University of Kansas Medical Center

Jason R. Stubbs – Principal Investigator

2. Bio-Tech D3-1,000 IU and 50,000 IU University of Rochester Medical Center

Peppone L.J., Huston A.J., Reid M.E., Rosier R.N., Zakharia Y., Trump D.L., Mustian K.M., Janelsins M.C., Purnell J.Q., Morrow G.R.

3. Bio-Tech D3-50,000 IU and 1000 IU Georgia Health Sciences University

Yanbin Dong, M.D., Ph.D. – Study Director Jennifer Pedersen-White, D.O.

4. Bio-Tech D3-5,000 IU University of Minnesota – Clinical and Translational Science Institute; Minneapolis Medical Research Foundation

Cary Mariash, M.D. – Study Director Shaban Nazarian, M.D. – Principal Investigator Sidney Jones, M.D. – Study Chair

5. Bio-Tech D3-50,000 IU Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH); Medical College of Wisconsin

Multi-site study Peter L. Havens, M.S., M.D. – Study Chair

6. Bio-Tech D3-50,000 IU and 1000 IU Georgia Health Sciences University

Yanbin Dong, M.D., Ph.D. – Study Director Jennifer Pedersen-White, D.O.

7. Bio-Tech D3-50,000 IU Emory University Divisions of Nephrology and Cardiology

Haimanot Wasse, M.D. – Principal Investigator

8. Bio-Tech D3-50,000 IU Medical College of Wisconsin; University of California at San Francisco; St. Jude Children’s Research Hospital; United States Department of Agriculture Human Nutrition Research Center; University of South Florida College of Medicine; University of Alabama at Birmingham

Peter L. Havens, M.S., M.D. – Study Chair

9. Bio-Tech D3-2,500 IU National Institute on Aging (NIA); Rutgers University

Sue Shapses, Ph.D., R.D. – Principal Investigator Stephen Schneider, M.D. Robert Brolin, M.D.

10. Bio-Tech D3-5000 IU Cystic Fibrosis Therapeutics Foundation; University of North Carolina School of Medicine; FDA Office of Orphan Products Development

Robert Aris, M.D. – Study Chair

11. Bio-Tech D3-50,000 IU University Hospital Case Medical Center

Rebecca S. Boxer, M.D. – Principal Investigator

12. Bio-Tech D3-2000 IU and 4000 IU National Institute of Allergy and Infectious Diseases (NIAID); Autoimmunity Centers of Excellence; Feinstein Institute for Medical Research; Medical University of South Carolina

Multi-site study Cynthia Aranow, M.D. – Study Chair Diane Karmen, M.D. – Study Chair

13. Bio-Tech D3-4000 IU National Institute of Allergy and Infectious Diseases (NIAID); Food and Drug Administration (FDA); National Jewish Health; University of California, San Diego; Oregon Health and Science University

Richard Gallo, M.D., Ph.D. – Study Chair

14. Bio-Tech D3-50,000 IU Charles Drew University of Medicine and Science Morehouse School of Medicine

David Martins, M.D. Naureen Tareen, M.D.

15. Bio-Tech D3-50,000 IU Emory Global Health Institute; Republic of Georgia National Tuberculosis Program; National Center of Tuberculosis and Lung Diseases; Rollins School of Public Health

Thomas R. Ziegler, M.D. – Principal Investigator

16. Bio-Tech D3-1000 IU and 50,000 IU University of Chicago

Jayant M. Pinto, M.D. – Principal Investigator

17. Bio-Tech D3-4000 IU University of Kansas Medical Center

Leigh M. Eck, M.D. – Principal Investigator Candice Rose, M.D. Leland Graves III, M.D. Barbara P. Lukert, M.D.

18. Bio-Tech D3-50,000 IU Memorial Sloan-Kettering Cancer Center

Kathleen Wesa, M.D. – Principal Investigator Barrie Cassileth, Ph.D.

19. Bio-Tech D3-5000 IU and 50,000 IU Mayo Clinic

Bernard R. Lee, Pharm.D. – Principal Investigator Thomas D. Thacher, M.D. – Principal Investigator Michael E. Meekins, Pharm.D. – Study Director

20. Bio-Tech D3-4000 IU The University of Chicago Medical Center

Robert Naclerio, M.D. – Principal Investigator

21. Bio-Tech D3-50,000 IU Mount Sinai School of Medicine; National Kidney Foundation

Peter Heeger, M.D. – Principal Investigator Anita Mehrotra, M.D. – Study Director

22. Bio-Tech D3-1000 IU Jewish Home, San Francisco; National Institute on Aging (NIA)

Janice B. Schwartz, M.D. – Principal Investigator

23. Bio-Tech D3-1000 IU and 50,000 IU University of Michigan Medical Center

Barry E. Bleske, Pharm. D. – Principal Investigator

24. Bio-Tech D3-50,000 IU and 4000 IU National Heart, Lung, and Blood Institute (NHLBI) AsthmaNet; Pennsylvania State University College of Medicine

David T. Mauger, Ph.D. – Principal Investigator

25. Bio-Tech D3-1000 IU and 5000 IU Children’s Hospital of Philadelphia; Division of Endocrinology/Diabetes

Sheela N. Magge, M.D. – Principal Investigator

26. Bio-Tech D3-50,000 IU Tufts University; Jean Mayer USDA Human Nutrition Research Center on Aging

Bess Dawson-Hughes, M.D. – Principal Investigator

27. Bio-Tech D3-50,000 IU University of Wisconsin, Madison; University of Alabama at Birmingham; University of Rochester University of Minnesota – Clinical and Translational Science Institute; Lahey Clinic; Urology San AntonioJoel W. Slaton, M.D. – Principal Investigator
28. Bio-Tech D3-50,000 IU University of Rochester Cancer Center

Luke J. Peppone, Ph.D. – Principal Investigator

29. Bio-Tech D3-5000 IU and 50,000 IU Department of Veterans Affairs , VA Medical Center – BronxJames B. Post, M.D. – Principal Investigator
30. Bio-Tech D3- 50,000 IU University Hospitals Case Medical Center, Cleveland Clinic, Case Comprehensive Cancer Center

Smitha Krishnamurthi, M.D. – Principal Investigator

 

31. Bio-Tech D3- 50,000 IU

 

Ohio State University, Division of Infectious Diseases

Abigail Norris Turner, Ph.D. – Principal Investigator

32. Bio-Tech D3-5000 IU and 50,000 IU Mayo Clinic

Thomas D. Thacher, M.D. – Principal Investigator

33. Bio-Tech D3-5000 IU and 50,000 IU Medical College of Georgia

Yanbin Dong, M.D., Ph.D.

34. Bio-Tech D3-4000 IU Florida International University – Human Nutrition Laboratory

Fatma E. Huffman, Ph.D. – Principal Investigator

35. Bio-Tech D3-1000 IU Pennington Biomedical Research Center – Baton Rouge, Louisiana

Alok K. Gupta, M.D. – Principal Investigator

36. Bio-Tech D3-50,000 IU The Kidney Institute, University of Kansas Medical Center

Jason R. Stubbs – Principal Investigator

37. Bio-Tech D3-50,000 IU University of Arizona

Clara Curiel, M.D. – Principal Investigator

38. Bio-Tech D3-5,000 IU International Heart Institute of Montana Saint Patrick Hospital and Health Sciences CenterBradley Berry, M.D. – Principal Investigator Heidi Moretti, M.S., R.D.
39. Bio-Tech D3-50,000 IU Emory University, Cystic Fibrosis Foundation Multi-site studyVin Tangpricha, M.D., Ph.D . – Principal Investigator
40. Bio-Tech Vitamin K1 (5 mg) Queens University and Kingston General Hospital Ontario, Canada

Rachel Holden, M.D. – Principal Investigator

41. Bio-Tech D3-50,000 IU Massachusetts General Hospital

Sadeq A. Quraishi, M.D. – Principal Investigator

42. Bio-Tech D3-50,000, 5000, 1000 IU Albert Einstein College of Medicine and The Children’s Hospital at Montefiore

Hina J. Talib, M.D., Tulasi Ponnapakkam, Ph.D., Robert Gensure, M.D., Unab I. Khan, M.D., Ping Zhou, M.D., Susan M. Coupey, M.D.